Voya Financial Advisors’s BioNTech BNTX Stock Holding History

Voya Financial Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,504	Closed	-$470K	–	292
2021 Q1	$470K	Buy	+4,504	New	+$478K	0.02%	441

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Voya Financial Advisors's BNTX Position: Q2 2021 in Review

Voya Financial Advisors sold out of BioNTech (BNTX) in Q2 2021, closing a stake of 4,504 shares — an estimated $470K sold.

Voya Financial Advisors first reported a position in BNTX in Q1 2021 and held it in 1 quarter. The position peaked at $470K in Q1 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

Voya Financial Advisors reported no remaining BioNTech position as of Q2 2021 after selling out during the quarter.
Voya Financial Advisors sold 4,504 BioNTech shares in Q2 2021, an estimated $470K.
Voya Financial Advisors first reported a position in BioNTech in Q1 2021 and held it in 1 quarter.
Voya Financial Advisors's BioNTech position peaked at $470K in Q1 2021.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on Voya Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.